Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 25, 2017 - Issue 3
Submit an article Journal homepage
3,510
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Multiple Sclerosis-Associated Uveitis

Emmett T. Cunningham Jr.Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USA;Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA;The Francis I. Proctor Foundation, UCSF School of Medicine, San Francisco, California, USACorrespondence[email protected]
View further author information
, MD, PhD, MPH,
Carlos E. PavesioMoorfields Eye Hospital and Biomedical Research Center, NHS Foundation Trust, London, UKView further author information
, MD, FRCOphth,
Debra A. GoldsteinDepartment of Ophthalmology, Northwestern Feinberg School of Medicine, Chicago, Illinois, USAView further author information
, MD,
Farzin ForooghianDepartment of Ophthalmology, St. Paul’s Hospital, Vancouver, British Columbia, CanadaView further author information
, MD, MSc, FRCSC &
Manfred ZierhutCentre for Ophthalmology, University Tuebingen, Schleichstrasse, Tuebingen, GermanyView further author information
, MD
Pages 299-301 | Published online: 11 Jul 2017

References

  • Brownlee WJ, Hardy TA, Fazekas F, et al. Diagnosis of multiple sclerosis: Progress and challenges. Lancet. 2017;389(10076):1336–1346.
  • Gordon LK, Goldstein DA. Gender and uveitis in patients with multiple sclerosis. J Ophthalmol. 2014;2014:565262. doi:10.1155/2014/565262 Epub 2014 May 7.
  • Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83–99.
  • Barnes D, McDonald WI. The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements. J Neurol Neurosurg Psychiatry. 1992;55:863–868.
  • Tilikete C, Jasse L, Vukusic S, et al. Persistent ocular motor manifestations and related visual consequences in multiple sclerosis. Ann N Y Acad Sci. 2011 Sep;1233:327–334.
  • Olsen TG, Frederiksen J. The association between multiple sclerosis and uveitis. Surv Ophthalmol. 2017;62(1):89–95. doi:10.1016/j.survophthal.2016.07.002. Epub 2016 Aug 1
  • Petrushkin H, Kidd D, Pavesio C. Intermediate uveitis and multiple sclerosis: To scan or not to scan. Br J Ophthalmol. 2015;99(12):1591–1593.
  • Comi G, Radaelli M, Soelberg Sørensen P. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet. 2017;389(10076):1347–1356.
  • Forooghian F. Uveitis and the diagnosis of multiple sclerosis. Can J Neurol Sci. 2017;44(3):334–335.
  • Jouve L, Benrabah R, Héron E, et al. Multiple sclerosis-related uveitis: Does MS treatment affect uveitis course? Ocul Immunol Inflamm. 2017;25(3):302–307. doi:10.3109/09273948.2015.1125508
  • Hedayatfar A, Falavarjani KG, Soheilian M, et al. Mycophenolate mofetil for the treatment of multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2017;25(3):308–314. doi:10.1080/09273948.2016.1178302
  • Khalil DH, Said MM, Abdelhakim MA, et al. OCT and visual field changes as useful markers for follow-up of axonal loss in multiple sclerosis in Egyptian patients. Ocul Immunol Inflamm. 2017;25(3):315–322. doi:10.3109/09273948.2016.1151895
  • Cunningham ET Jr, Acharya N, Kempen JH, et al. Design and interpretation of clinic-based studies in uveitis. Ocul Immunol Inflamm. 2015;23(4):267–270.
  • Becker MD, Heiligenhaus A, Hudde T, et al. Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol. 2005;89(10):1254–1257.
  • Mackensen F, Jakob E, Springer C, et al. Interferon versus methotrexate in intermediate uveitis with macular edema: Results of a randomized controlled clinical trial. Am J Ophthalmol. 2013;156(3):478–486.
  • Afshar AR, Fernandes JK, Patel RD, et al. Cystoid macular edema associated with fingolimod use for multiple sclerosis. JAMA Ophthalmol. 2013;131(1):103–107.
  • Cunningham ET Jr, Zierhut M. TNF inhibitors for uveitis: Balancing efficacy and safety. Ocul Immunol Inflamm. 2010;18(6):421–423.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.